Diabetes Information

Benfotiamine And Diabetic Retinopathy


Damage from diabetes can occur in different areas of the eye. It can occur to the cornea, nerves controlling the muscles of the eye, the lens, optic nerve and retina. The retina is the complication that most people and medical professionals think of first in terms of diabetic complications.

Diabetic retinopathy is simply damage to the light sensitive retina. This damage is brought about by hyperglycemia, the medical term for high blood sugar. Retinopathy is directly responsible for approximately 12,000 to 24,000 cases of legal blindness every year in the USA alone. It is reported that there are over 200,000 cases each year globally.

Diabetic complications are even more insidious than these numbers because there are several other types of diabetic eye disease created wholly or in part by high blood sugar in diabetics.

What Can Be Done To Prevent Eye Disease?

It stands to reason that the more informed a person is about a particular situation the better equipped they will be to handle it. Diabetic eye disease is just such a case in point. We need to think of the whole person and not just the eyes when discussing diabetic education because diabetic complications run from eye disease, heart disease, nerve damage, kidney damage, etc. Although benfotiamine has been found useful for all of the above, for the sake of this article in terms of prevention, we will discuss diabetic eye disease in terms of diabetic retinopathy.

Diabetic retinopathy is a disease that every diabetic faces the possibility of suffering from somewhere in the course of their disease. The better patients of diabetes are equipped to handle their disease, the lower their risk that they will develop retinopathy. If retinopathy does develop in a patient who is doing all he/she can do to lessen the impact of blood sugar on their bodies, the better chance that they can live productive lives despite the complications and the slower such complications will progress.

What Works Best?

Unfortunately, there are very few options that are showing much promise for the diabetic in terms of diabetic complications. Benfotiamine has been suggested recently to be a strong deterrent against the development of diabetic retinopathy and also shown to slow its progression significantly if it develops. It is showing great promise in the arena of retinopathy, neuropathy and heart/circulatory conditions brought about by excess sugar in the cells.

Benfotiamine, a lipid soluble derivative of water soluble vitamin B1 (thiamine), has been used for the past 12 years in Europe for the treatment of neuropathy, retinopathy as well as heart and circulatory conditions and has shown no adverse effects.

Much of the current research on benfotiamine can be discovered by typing the term benfotiamine into a search engine such as google, AOL, yahoo, etc.

Conclusion

Diabetic complications are a reality that must be an accepted possibility for every diabetic. Diabetic education is highly necessary so that the diabetic community is able to make informed decisions as to their treatment and prevention methodologies. There are few things that show great promise in preventing and/or helping neuropathy, retinopathy, heart and circulatory problems brought about by diabetes. Keeping blood sugar levels close to normal along with adequate exercise in line with the abilities of each individual has shown to help slow the onset of diabetic complications.

Benfotiamine is a nutritional supplement that has shown to be helpful in Europe over the past 12 years in terms of diabetic complications and is now available in the United States, and might be worth the time to investigate further. How about for the diabetic who faces the insidious nature of diabetic complications?

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy. He can be reached at:

Phone: 505.354.0526

web site: http://www.emuhealthproducts.com/benfotiamine.html


MORE RESOURCES:

ABC News

Twofold Action Urged for Pre-Diabetes
Washington Post, United States - 11 hours ago
Pre-diabetes occurs when blood sugar levels or impaired glucose tolerance is elevated, but not quite to the point defined as diabetes. ...
Diabetes Experts Recommend One-Two Punch for Treating Patients ... MarketWatch
One-Two Punch Urged for Pre-Diabetes Patients First Coast News
New Recommendations for Prediabetes WebMD
KOAA
all 23 news articles


Astra seeks approval for diabetes drug
Forbes, NY - 12 hours ago
The two companies began collaborating in January 2007 to develop and sell two investigational drugs for type 2 diabetes, saxagliptin and dapagliflozin. ...
Bristol-Myers Squibb, AstraZeneca submit market clearance ... RTT News
AstraZeneca, Bristol-Myers submit US and EU application for ... Trading Markets (press release)
AstraZeneca says submits application in US and EU for saxagliptin ... Hemscott
RTT News
all 20 news articles


Ontario Now

Diabetes expert lauds insulin pump coverage
London Free Press, Canada - Jul 22, 2008
By JOHN MINER, AND NEWS SERVICES The Ontario government decision to start paying the cost of insulin pumps for adults with Type 1 diabetes was applauded ...
Ontario to invest $741 million in diabetes treatment and prevention The Canadian Press
Ontario zeroes in on diabetes NorthernLife.ca
Ontario Will Pay For Insulin Pumps For Adult Diabetes Type 1 Patients Medical News Today
Peterborough Examiner - AHN
all 69 news articles


Glass of juice a day increases diabetes risk
Telegraph.co.uk, United Kingdom - 18 hours ago
Researchers found women who drink a glass of fruit juice every morning may be 18 per cent more likely to get type two diabetes, the kind normally triggered ...


Latino Diabetes Association Launches New Website
Newswire Today (press release), UK - 13 hours ago
New Website Features a Health Blog to answer Diabetes related questions by Registered Nurses, Physician Assistants or Doctors. Diabetes is one of the ...


Pre-diabetes must be treated, doctors urge
USA Today - Jul 22, 2008
Diabetes experts created the first recommendations Tuesday for the treatment of people with pre-diabetes in the hopes of curbing the diabetes epidemic. ...


Santarus to promote Depomed diabetes drug
CNNMoney.com - Jul 22, 2008
NEW YORK (Associated Press) - Santarus Inc. said Tuesday it agreed to promote Depomed Inc.'s diabetes drug Glumetza in the US, and will pay Depomed up to ...
Depomed Gets $12M Up Front in Diabetes Deal with Santarus Therapeutics Daily (subscription) (press release)
Santarus and Depomed Announce US Promotion Agreement for GLUMETZA ... Business Wire (press release)
Santarus, Depomed reach promotion agreement for Depomed's Glumetza ... RTT News
all 17 news articles


Researchers develop gameplan to treat pre-diabetes
KARE, MN - 10 hours ago
That gap is what doctors call "pre-diabetes." "Somebody with pre-diabetes usually has absolutely no symptoms and they may not even know they're at risk," ...


Health Science Center diabetes researchers form partnership with ...
Milwaukee Business Journal, WI - 19 hours ago
Diabetes researchers at the University of Texas Health Science Center at San Antonio have agreed to collaborate with Metabolon Inc. in a new partnership ...


The Money Times

Diabetes drug maker Amylin posts wider second-quarter loss
San Diego Union Tribune, United States - Jul 22, 2008
By Terri Somers The expense of developing a once-weekly version of its diabetes drug, Byetta, led to a wider second-quarter loss, Amylin Pharmaceuticals ...
Anemic Amylin's Signs of Recovery Motley Fool
Amylin posts wider second-quarter net loss guardian.co.uk
Amylin posts wider Q2 net loss Business Spectator
all 18 news articles

Diabetes - Google News

home | site map
© 2006